Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

CYPH vs GALT: stock comparison and AI forecast

Cypherpunk Technologies Inc. (CYPH) and Galectin Therapeutics Inc (GALT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

CYPH Cypherpunk Technologies Inc.

Market Cap
$310M
P/E Ratio
4.4x
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

GALT Galectin Therapeutics Inc

Market Cap
$301M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

CYPH · GALT

Key facts

  • CYPH and GALT have similar market capitalizations ($310M and $301M).
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricCYPHGALT
Market Cap$310M$301M
P/E Ratio4.43x–
P/B Ratio2.23x–
EPS$0.65$-0.50
Book Value/Share$1.29–

Profitability & Margins

MetricCYPHGALT
ROE-0.6%–
ROA-0.6%-187.8%
ROIC-12.6%11.4%
Tax Rate108.0%–

Financial Health

MetricCYPHGALT
Current Ratio79.19x0.10x
D/E Ratio0.03x–
Financial Leverage1.03x–
Interest Coverage-2788.6x-9.2x
Working Capital$136M-$137M

Cash Flow

MetricCYPHGALT
Operating Cash Flow-$21M-$16M

Income Statement

MetricCYPHGALT
Operating Income-$18M-$16M
Net Income-$880K-$28M
R&D Expense$3M$9M

Dividend & Shareholder Information

MetricCYPHGALT
Shares Outstanding108M101M
FAQ

CYPH vs GALT: stock comparison and AI forecast

Which is bigger, CYPH or GALT?

CYPH and GALT have similar market capitalizations ($310M and $301M).

Which one does Intratio's AI model rank higher, CYPH or GALT?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.